SEC Form 4 · accession 0001209191-18-063290
Odonate Therapeutics, Inc. · ODT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John G Lemkey
Officer — Chief Operating Officer
Period of report
Dec 14, 2018
Accepted (ET)
Dec 18, 2018 · 5:59 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001717452
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 14, 2018 | A | 64 | $12.85 | A | 866 | D | |
| Common StockF2 | holding | — | — | — | 12,822,338 | I | By LP |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F3 | $15.12 | Dec 14, 2018 | A | 64 | A | — | Dec 14, 2028 | Common Stock | 64 | 64 | D |
Explanation of responses
- F1These shares were acquired on 12/14/2018 through the Odonate Therapeutics, Inc. 2017 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).
- F2The securities are beneficially owned by Tang Capital Partners, LP ("TCP"). Tang Capital Management, LLC ("TCM") is the general partner of TCP. The shares reported as beneficially owned by TCP include a total of 154,285 shares of common stock that are held of record by Odonate Holdings, LLC ("Holdings"). Holdings has granted a proxy to TCP giving TCP the sole authority to vote such shares. John Lemkey is the Chief Operating Officer of Odonate Therapeutics, Inc., as well as Chief Operating Officer of TCM. Mr. Lemkey has a pecuniary interest in a portion of the shares beneficially held by TCP.
- F3The stock options vest with respect to 25% of the underlying shares on 12/14/2019, with the remaining shares vesting in equal monthly installments over the following three years, subject to the Reporting Person's continued service to the Issuer through each vesting date.